Celularity Inc — Director's Dealing 2025

Feb 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2025-02-17

Reporting Person: Brigido Stephen (Pres., Functional Regeneration)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-17	Class A Common Stock	M	10000	—	Acquired	11641	Direct
2025-02-17	Class A Common Stock	F	3272	$2.14	Disposed	8369	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-17	Restricted Stock Units	$	M	10000	Disposed		Class A Common Stock (10000)	Direct

Footnotes

F1: Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On February 17, 2023, the reporting person was granted 10,000 RSUs, which vested on February 17, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on February 22,2023.

F2: This line reflects the tax withholding on the vesting of RSUs that vested on February 17, 2025.

F3: Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock.

F4: On February 17, 2023, the reporting person was granted 10,000 RSUs, which vested on February 17, 2025. The Class A Common Stock into which such vested RSUs converted on February 17, 2025 is reported in Table I on this Form 4.